Dermatomyositis affects children and adults, females more often than males, and is traditionally closely associated with internal malignancy. Approximately 30% of patients with dermatomyositis have a malignancy, most commonly of the lung, ovary, breast or stomach.1 Urogenital malignancies associated with dermatomyositis are relatively rare although several cases associated with transitional cell carcinoma of the bladder have been documented.2 To our knowledge we report the first case of dermatomyositis associated with urachal adenocarcinoma. CASE REPORT A 47-year-old female presented with a 4-month history of gross hematuria and edema of the upper body. The patient also reported a 10 kg. weight loss. Physical examination revealed erythema affecting the face, shoulders, chest and back. The face was especially swollen with edema and erythema. Cystoscopy and computerized tomography (CT) demonstrated a solid mass in the dome of the bladder (fig. 1). Biopsy of the skin and deltoid muscle showed epidermal atrophy with a thickened basement membrane, and perivascular and interstitial inflammatory infiltrates. The muscle revealed myofiber degeneration and atrophy, increased interstitial collagen and endomysial inflammatory infiltrates (fig. 2, A). These findings were consistent with dermatomyositis. Laboratory tests demonstrated increased creatine phosphokinase (937 units per l., normal 35 to 165), increased lactic dehydrogenase (1,027 units per l., normal 203 to 450) and increased carcinoembryogenic antigen (46.3 ng./ml., normal less than 5.0). Transurethral resection of the bladder tumor showed moderately differentiated adenocarcinoma invading the bladder wall (fig. 2, B). Consequently, the clinical diagnosis was dermatomyositis associated with urachal adenocarcinoma. For the treatment of dermatomyositis 1 mg./kg. prednisolone per day was administered, and an immediate effect was observed with regard to the skin and muscle symptoms. Total cystectomy was not recommended because of a lung metastasis detected on CT, and the patient instead underwent pelvic irradiation (total 50 Gy.) and 2 courses of systemic chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin. The response to these therapies was minimal. One year after diagnosis, the patient died of multiple metastases to the liver and lung. However, the characteristic symptoms of dermatomyositis were well controlled by prednisolone until the end of her life.
Read full abstract